Nothing Special   »   [go: up one dir, main page]

NO994930D0 - Preventiver og hjelpemidler for ulcerös kolitt og/eller crohn's sykdom - Google Patents

Preventiver og hjelpemidler for ulcerös kolitt og/eller crohn's sykdom

Info

Publication number
NO994930D0
NO994930D0 NO994930A NO994930A NO994930D0 NO 994930 D0 NO994930 D0 NO 994930D0 NO 994930 A NO994930 A NO 994930A NO 994930 A NO994930 A NO 994930A NO 994930 D0 NO994930 D0 NO 994930D0
Authority
NO
Norway
Prior art keywords
remedies
crohn
disease
prevents
ulcerative colitis
Prior art date
Application number
NO994930A
Other languages
English (en)
Other versions
NO994930L (no
Inventor
Masaaki Ishizuka
Kennji Maeda
Tomio Takeuchi
Tadayoshi Shiraishi
Masakazu Fukushima
Original Assignee
Zaidan Hojin Biseibutsu
Tahio Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaidan Hojin Biseibutsu, Tahio Pharmaceutical Co Ltd filed Critical Zaidan Hojin Biseibutsu
Publication of NO994930D0 publication Critical patent/NO994930D0/no
Publication of NO994930L publication Critical patent/NO994930L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
NO994930A 1997-04-09 1999-10-08 Preventiver og hjelpemidler for ulcerös kolitt og/eller Crohns sykdom NO994930L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9068897 1997-04-09
PCT/JP1998/001614 WO1998044916A1 (fr) 1997-04-09 1998-04-08 Medicaments de prevention ou de traitement de la recto-colite hemorragique et/ou de la maladie de crohn

Publications (2)

Publication Number Publication Date
NO994930D0 true NO994930D0 (no) 1999-10-08
NO994930L NO994930L (no) 1999-12-08

Family

ID=14005483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994930A NO994930L (no) 1997-04-09 1999-10-08 Preventiver og hjelpemidler for ulcerös kolitt og/eller Crohns sykdom

Country Status (11)

Country Link
US (1) US6160017A (no)
EP (1) EP0987022B1 (no)
JP (1) JP4019158B2 (no)
KR (1) KR100356899B1 (no)
AT (1) ATE316373T1 (no)
AU (1) AU727289B2 (no)
CA (1) CA2288966C (no)
DE (1) DE69833317D1 (no)
HU (1) HUP0000716A3 (no)
NO (1) NO994930L (no)
WO (1) WO1998044916A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011066A1 (ja) * 2005-07-22 2007-01-25 Kaneka Corporation 繊維芽細胞賦活剤、コラーゲン産生促進剤、コラーゲン収縮促進剤、ヒアルロン酸産生促進剤、ａｔｐ産生促進剤、メラニン生成抑制剤、皮膚外用剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4078397B2 (ja) * 1994-10-14 2008-04-23 財団法人微生物化学研究会 下痢の予防及び治療剤

Also Published As

Publication number Publication date
HUP0000716A3 (en) 2000-10-30
US6160017A (en) 2000-12-12
AU6746898A (en) 1998-10-30
JP4019158B2 (ja) 2007-12-12
KR100356899B1 (ko) 2002-10-31
KR20010006136A (ko) 2001-01-26
AU727289B2 (en) 2000-12-07
CA2288966C (en) 2004-03-16
CA2288966A1 (en) 1998-10-15
WO1998044916A1 (fr) 1998-10-15
DE69833317D1 (de) 2006-04-13
EP0987022A1 (en) 2000-03-22
HUP0000716A2 (hu) 2000-09-28
EP0987022B1 (en) 2006-01-25
NO994930L (no) 1999-12-08
EP0987022A4 (en) 2004-03-31
ATE316373T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
BR9503406A (pt) Formulaçoes farmacêuticas adaptadas para inhibir para perda de osso em um ser humano
ATE121295T1 (de) Augentropfenarzneimittel.
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
UA41355C2 (uk) Засіб для лікування нейро-сніду
ES2052065T3 (es) Formulacion dispersable.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
AP9200355A0 (en) "Therapeutic agent"
EP0380989A3 (en) Plaster for transdermal administration
GR3032224T3 (en) Therapeutic agent for threatened abortion.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
NO994930D0 (no) Preventiver og hjelpemidler for ulcerös kolitt og/eller crohn's sykdom
FR2695297B1 (fr) Composition d'agent désinfectant.
NO874241D0 (no) Terapeutisk aktive salter.
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
ITMI931371A0 (it) Procedimento per la preparazione dell'erdosteina
GR77250B (no)
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
CA2099667A1 (en) Agent for treating hepatic diseases
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
FR2667779B1 (fr) Moniteur direct d'apn2e.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application